share_log

Aadi Bioscience Remains Actively Engaged In A Comprehensive Strategic Review To Maximize Shareholder Value

Benzinga ·  Nov 6 21:05

Aadi has not provided a specific timeline to complete this process and will provide further updates when appropriate.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment